Back to search

Article

Novel use of imatinib to treat mandibular fibrous dysplasia in Noonan's syndrome

2023-01-28

Abstract excerpt

Fibrous dysplasia of the mandible typically begins during toddler years and culminates during puberty. These lesions may cause jaw disfigurement and may not be amendable to surgery. Imatinib successfully has treated cherubism associated with SH3BP2 mutations, but similar lesions can present in other conditions such as Noonan syndrome. We report diagnosis of Noonan syndrome caused by a PTPN11 activating mutation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
da2b6a04-1002-5a7f-8b40-5135c95dc10a
DOI
10.22541/au.167492166.61754838/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel use of imatinib to treat mandibular fibrous dysplasia in Noonan's syndromeDOI 10.22541/au.167492166.61754838/v1
Select a neighboring publication to make it the new centre.